-
Mashup Score: 0
DESTIN, Fla. — Cell senescence may represent the “most exciting” development in the potential treatment of osteoporosis, according to Michael R. McClung, MD, of Australian Catholic University and the Oregon Osteoporosis Center.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
DESTIN, Fla. — Genetic and environmental factors, as well as autoantibodies, “likely play a role” in the expression of systemic sclerosis, according to Zsuzsanna McMahan, MD, MHS, of Johns Hopkins University School of Medicine.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
DESTIN, Fla. — Adjustments made to the dosing and administration of immunomodulatory drugs may not have much impact on COVID-19 vaccine immunogenicity among patients with autoimmune and inflammatory rheumatic disease, according to data.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0VIDEO: Switching drug class can result in ‘home run’ response in rheumatoid arthritis - 2 year(s) ago
DESTIN, Fla. — Switching to a different drug class with a different mechanism of action can improve response in patients with difficult-to-treat rheumatoid arthritis, according to Janet Pope, MD, of Western University, in Ontario, Canada.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Among the many unanswered questions about calcium pyrophosphate deposition — formerly called “pseudogout” — perhaps the most important is whether it causes osteoarthritis, a speaker said at the Congress of Clinical Rheumatology East.“I am hoping I can drum up some enthusiasm for what really has been an understudied disease, yet very common,” Sara K. Tedeschi,
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
DESTIN, Fla. — Physicians considering opioids for pain should perform manual calculations before consulting conversion charts and online calculators, according to a speaker at the Congress of Clinical Rheumatology East. “[Morphine equivalent daily dosage (MEDD)] is a badly flawed concept, and it fails to take pharmacogenetic differences into account, which are important,”
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Among the many unanswered questions about calcium pyrophosphate deposition — formerly called “pseudogout” — perhaps the most important is whether it causes osteoarthritis, a speaker said at the Congress of Clinical Rheumatology East.“I am hoping I can drum up some enthusiasm for what really has been an understudied disease, yet very common,” Sara K. Tedeschi,
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Among the many unanswered questions about calcium pyrophosphate deposition — formerly called “pseudogout” — perhaps the most important is whether it causes #osteoarthritis #CCR2022 https://t.co/3HULRC4Flx
-
-
Mashup Score: 0
DESTIN, Fla. — Physicians considering opioids for pain should perform manual calculations before consulting conversion charts and online calculators, according to a speaker at the Congress of Clinical Rheumatology East. “[Morphine equivalent daily dosage (MEDD)] is a badly flawed concept, and it fails to take pharmacogenetic differences into account, which are important,”
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
DESTIN, Fla. — Physicians considering opioids for pain should perform manual calculations before consulting conversion charts and online calculators, according to a speaker at the Congress of Clinical Rheumatology East. “[Morphine equivalent daily dosage (MEDD)] is a badly flawed concept, and it fails to take pharmacogenetic differences into account, which are important,”
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Rheumatologists are likely to be at the “forefront” of diagnosing scleroderma skin disorders and other dermatological conditions, a speaker said at Congress of Clinical Rheumatology East.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
Cell senescence may represent the “most exciting” development in the potential treatment of #osteoporosis, according to Michael R. McClung, MD #CCR2022 https://t.co/PQ3Q7IZ1F5